The study by Tankiewicz-Kwedlo et al. demonstrated that the effects of Epo therapy on tumor growth dynamics were more pronounced in HT-29 cell xenografts compared to DLD-1 cell xenografts [55]. This evidence concerns the gene EPO and neoplasm.